Menu Search
Equities

Phase Holographic Imaging PHI AB

PHI:AKT

Phase Holographic Imaging PHI AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)1.90
  • Today's Change-0.015 / -0.79%
  • Shares traded6.27k
  • 1 Year change-69.73%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Phase Holographic Imaging PHI AB grew revenues 6.16% from 9.90m to 10.51m while net income improved from a loss of 23.19m to a smaller loss of 20.18m.
Gross margin71.06%
Net profit margin-239.04%
Operating margin-202.85%
Return on assets-56.73%
Return on equity-408.26%
Return on investment-88.25%
More ▼

Cash flow in SEKView more

In 2024, cash reserves at Phase Holographic Imaging PHI AB fell by 5.14m. Cash Flow from Financing totalled 21.54m or 204.93% of revenues. In addition the company used 16.76m for operations while cash used for investing totalled 9.92m.
Cash flow per share-0.7483
Price/Cash flow per share--
Book value per share-0.0273
Tangible book value per share-1.07
More ▼

Balance sheet in SEKView more

Phase Holographic Imaging PHI AB has a Debt to Total Capital ratio of 104.11%, a lower figure than the previous year's 180.56%.
Current ratio0.3953
Quick ratio0.1916
Total debt/total equity--
Total debt/total capital1.04
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.